Abbreviations:
Cancer
CHEMOTHERAPY INDUCED NEUTROPENIA, CANCER
adverse eventsabsolute neutrophil countcomplete blood countchemotherapy induced neutropeniafebrile neutropeniagranulocyte-colony-stimulating factorgradepegylated granulocyte-colony-stimulating factor,upper limit normalData sharing not applicable to this article as no datasets were generated or analyzed during the current study.This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2021R1F1A1047192). The research was supported in part by the Korean Cancer Study Group (KCSG PC22-11).The authors have no conflicts of interest to disclose.Trial registration: Clinical Research Information Service identifier: KCT0007694.How to cite this article: Park K, Jeon Y-K, Kim JH, Choi Y, Kim J-J, Oh S-B, Oh SY, Hong YJ, Huh SJ, Kim I, Shin SH. Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial. Medicine 2023;102:20(e33638).